Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Inclusion Criteria: * Male or female, aged 30 to 65 years. * Chosen an Ultherapy™ treatment as part of their treatment regimen. * Subject in good health. * Skin laxity on the face and neck. * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the followup period. * Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study Exclusion Criteria: * Known sensitivity to lidocaine or any other anesthetic of the amide type. * History of anaphylactic shock. * Presence of an active systemic or local skin disease that may affect wound healing. * Current therapy with class I antiarrhythmic drugs (e.g., tocainide, mexiletine). * Known or suspected hypersensitivity to LMX-4 active substance, or any of the amide-type local anaesthetics, or any of the excipients (protocol section 10.3). * Severe solar elastosis. * Excessive subcutaneous fat in the face and neck. * Body mass index of 30 or greater. * Excessive skin laxity on the face and neck. * Significant scarring in areas to be treated. * Significant open facial wounds or lesions. * Severe or cystic acne on the face. * Presence of a metal stent or implant in the facial area to be treated.